Cargando…
A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma
BACKGROUND: Colon adenocarcinoma (COAD) is a fatal disease, and its cases are constantly increasing worldwide. Further, the therapeutic and management strategies for patients with COAD are still unsatisfactory due to the lack of accurate patient classification and prognostic models. Therefore, our s...
Autores principales: | Cheng, Xuehua, Wei, Yong, Fu, Yugang, Li, Jiacheng, Han, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755665/ https://www.ncbi.nlm.nih.gov/pubmed/36532007 http://dx.doi.org/10.3389/fimmu.2022.1052182 |
Ejemplares similares
-
Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022) -
Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023) -
A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023) -
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
por: Li, Xinyu, et al.
Publicado: (2020) -
A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)